Furong Capital
29
26M
26
2.90
3
0.10
1
- Stages of investment
- Areas of investment
Summary
In 2014 was created Furong Capital, which is appeared as VC. The venture was found in Asia in China. The main office of represented VC is situated in the Shanghai.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Furong Capital, startups are often financed by Sunyard, Puhua Capital, Matrix Partners China. The meaningful sponsors for the fund in investment in the same round are Shenzhen Guozhong Venture Capital Management, Northern Light Venture Capital, Morningside Venture Capital. In the next rounds fund is usually obtained by ZWC Partners, IDG Capital, GSR Ventures.
The fund is generally included in less than 2 deals every year. The high activity for fund was in 2019. Speaking about the real fund results, this VC is 55 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 5 - 10 millions dollars.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular fund investment industries, there are Transportation, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Genedock, Kangpu Bio-Pharma.
Investments analytics
Analytics
- Total investments
- 29
- Lead investments
- 3
- Exits
- 1
- Rounds per year
- 2.90
- Follow on index
- 0.10
- Investments by industry
- Health Care (11)
- Biotechnology (10)
- Medical (5)
- Manufacturing (4)
- Transportation (3) Show 33 more
- Investments by region
-
- China (23)
- United States (1)
- Canada (2)
- Taiwan (1)
- Australia (1)
- Peak activity year
- 2023
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Group Appearance index
- 0.86
- Avg. company exit year
- 17
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Huikai Medical | 01 Jan 2021 | Health Care, Manufacturing, Medical Device | Early Stage Venture | Jiangsu, Suzhou, China | |
| Singlera | 01 Dec 2020 | Early Stage Venture | 154M | Shandong, Pudong, China |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.